nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—TAAR1—neck—salivary gland cancer	0.124	0.214	CbGeAlD
Amphetamine—CARTPT—connective tissue—salivary gland cancer	0.0888	0.154	CbGeAlD
Amphetamine—CARTPT—lymphoid tissue—salivary gland cancer	0.0649	0.112	CbGeAlD
Amphetamine—SLC22A3—tongue—salivary gland cancer	0.0522	0.0902	CbGeAlD
Amphetamine—CARTPT—Circadian rythm related genes—CRTC1—salivary gland cancer	0.0449	0.106	CbGpPWpGaD
Amphetamine—SLC18A2—Dopaminergic Neurogenesis—EN1—salivary gland cancer	0.041	0.0971	CbGpPWpGaD
Amphetamine—CARTPT—lymph node—salivary gland cancer	0.0366	0.0634	CbGeAlD
Amphetamine—CARTPT—Circadian rythm related genes—MC3R—salivary gland cancer	0.0366	0.0867	CbGpPWpGaD
Amphetamine—CARTPT—Circadian rythm related genes—PRKDC—salivary gland cancer	0.0277	0.0657	CbGpPWpGaD
Amphetamine—SLC22A3—parotid gland—salivary gland cancer	0.0244	0.0422	CbGeAlD
Amphetamine—SLC6A3—Dopaminergic Neurogenesis—EN1—salivary gland cancer	0.0244	0.0579	CbGpPWpGaD
Amphetamine—SLC22A3—saliva-secreting gland—salivary gland cancer	0.0234	0.0404	CbGeAlD
Amphetamine—MAOB—parotid gland—salivary gland cancer	0.0226	0.0391	CbGeAlD
Amphetamine—MAOB—saliva-secreting gland—salivary gland cancer	0.0216	0.0374	CbGeAlD
Amphetamine—SLC22A3—connective tissue—salivary gland cancer	0.0215	0.0372	CbGeAlD
Amphetamine—CARTPT—Circadian rythm related genes—TOP2A—salivary gland cancer	0.021	0.0498	CbGpPWpGaD
Amphetamine—MAOB—connective tissue—salivary gland cancer	0.0199	0.0344	CbGeAlD
Amphetamine—SLC22A5—parotid gland—salivary gland cancer	0.0178	0.0307	CbGeAlD
Amphetamine—SLC22A5—saliva-secreting gland—salivary gland cancer	0.017	0.0294	CbGeAlD
Amphetamine—TAAR1—G alpha (s) signalling events—MC3R—salivary gland cancer	0.0142	0.0337	CbGpPWpGaD
Amphetamine—SLC18A2—lymph node—salivary gland cancer	0.0125	0.0215	CbGeAlD
Amphetamine—SLC22A3—lymph node—salivary gland cancer	0.00887	0.0153	CbGeAlD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—EN1—salivary gland cancer	0.00857	0.0203	CbGpPWpGaD
Amphetamine—MAOB—lymph node—salivary gland cancer	0.0082	0.0142	CbGeAlD
Amphetamine—SLC6A2—lymph node—salivary gland cancer	0.0076	0.0131	CbGeAlD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.00728	0.0173	CbGpPWpGaD
Amphetamine—CARTPT—Circadian rythm related genes—PTEN—salivary gland cancer	0.00702	0.0166	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00677	0.016	CbGpPWpGaD
Amphetamine—CARTPT—Circadian rythm related genes—EP300—salivary gland cancer	0.00669	0.0159	CbGpPWpGaD
Amphetamine—SLC22A5—lymph node—salivary gland cancer	0.00645	0.0111	CbGeAlD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.00629	0.0149	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.00627	0.0149	CbGpPWpGaD
Amphetamine—CYP2A6—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.0059	0.014	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—MC3R—salivary gland cancer	0.00515	0.0122	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.0049	0.0116	CbGpPWpGaD
Amphetamine—CARTPT—Circadian rythm related genes—TP53—salivary gland cancer	0.00479	0.0114	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—CRTC1—salivary gland cancer	0.00451	0.0107	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.00434	0.0103	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0037	0.00877	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—MC3R—salivary gland cancer	0.00368	0.00872	CbGpPWpGaD
Amphetamine—DRD2—Hypothetical Network for Drug Addiction—MAP2K2—salivary gland cancer	0.00354	0.00839	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—MYB—salivary gland cancer	0.00328	0.00779	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0032	0.00759	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00319	0.00756	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00297	0.00705	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—MC3R—salivary gland cancer	0.00291	0.0069	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—PRKDC—salivary gland cancer	0.00279	0.00661	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—CRTC1—salivary gland cancer	0.00276	0.00654	CbGpPWpGaD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.00265	0.00629	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—MC3R—salivary gland cancer	0.00264	0.00627	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00249	0.0059	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.00229	0.00544	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.00228	0.00542	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—MC3R—salivary gland cancer	0.00225	0.00533	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0022	0.00523	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—TOP2A—salivary gland cancer	0.00211	0.00501	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—WNT5B—salivary gland cancer	0.00198	0.0047	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL17RD—salivary gland cancer	0.00192	0.00454	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.00184	0.00437	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.00178	0.00423	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MAML3—salivary gland cancer	0.00175	0.00416	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—PRKDC—salivary gland cancer	0.0017	0.00404	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.0017	0.00403	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.00158	0.00375	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00158	0.00374	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MC3R—salivary gland cancer	0.00156	0.0037	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ISYNA1—salivary gland cancer	0.00151	0.00357	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.0015	0.00357	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00147	0.00348	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00146	0.00347	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—DTX4—salivary gland cancer	0.00137	0.00324	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00135	0.00319	CbGpPWpGaD
Amphetamine—CYP2A6—Fluoropyrimidine Activity—TP53—salivary gland cancer	0.0013	0.00308	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—TOP2A—salivary gland cancer	0.00129	0.00306	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ISYNA1—salivary gland cancer	0.00127	0.00302	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—MARCKS—salivary gland cancer	0.00123	0.00291	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.00121	0.00287	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—MC3R—salivary gland cancer	0.0012	0.00285	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00116	0.00276	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00116	0.00275	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00114	0.00271	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PYGB—salivary gland cancer	0.00114	0.00271	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—FGF16—salivary gland cancer	0.00113	0.00268	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MARCKS—salivary gland cancer	0.00104	0.00246	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00101	0.0024	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MAML2—salivary gland cancer	0.000981	0.00233	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PYGB—salivary gland cancer	0.000965	0.00229	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000957	0.00227	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PHGDH—salivary gland cancer	0.00093	0.00221	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000906	0.00215	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ST3GAL4—salivary gland cancer	0.000895	0.00212	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—JAG1—salivary gland cancer	0.000837	0.00199	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—FGFR4—salivary gland cancer	0.000834	0.00198	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.000824	0.00195	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—FBXW7—salivary gland cancer	0.00082	0.00195	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AQP1—salivary gland cancer	0.000813	0.00193	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000803	0.0019	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PHGDH—salivary gland cancer	0.000787	0.00187	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ST3GAL4—salivary gland cancer	0.000758	0.0018	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ISYNA1—salivary gland cancer	0.000733	0.00174	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—PTEN—salivary gland cancer	0.000706	0.00167	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000693	0.00164	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—FOXO3—salivary gland cancer	0.000692	0.00164	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AQP1—salivary gland cancer	0.000688	0.00163	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—MC3R—salivary gland cancer	0.000679	0.00161	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—EP300—salivary gland cancer	0.000673	0.0016	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NUP62—salivary gland cancer	0.000645	0.00153	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—VCAN—salivary gland cancer	0.00064	0.00152	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MC3R—salivary gland cancer	0.000617	0.00146	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MARCKS—salivary gland cancer	0.000598	0.00142	CbGpPWpGaD
Amphetamine—SLC18A2—Transmission across Chemical Synapses—HRAS—salivary gland cancer	0.000591	0.0014	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000565	0.00134	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PYGB—salivary gland cancer	0.000556	0.00132	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NUP62—salivary gland cancer	0.000546	0.00129	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—VCAN—salivary gland cancer	0.000541	0.00128	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000522	0.00124	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—TP53—salivary gland cancer	0.000482	0.00114	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000463	0.0011	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—WNT5B—salivary gland cancer	0.000463	0.0011	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PHGDH—salivary gland cancer	0.000453	0.00107	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—HRAS—salivary gland cancer	0.000453	0.00107	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000452	0.00107	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00045	0.00107	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL17RD—salivary gland cancer	0.000447	0.00106	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ST3GAL4—salivary gland cancer	0.000436	0.00103	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—PTEN—salivary gland cancer	0.000432	0.00102	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CREBBP—salivary gland cancer	0.00042	0.000996	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—EP300—salivary gland cancer	0.000412	0.000976	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ISYNA1—salivary gland cancer	0.000411	0.000975	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAML3—salivary gland cancer	0.000409	0.000969	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AQP1—salivary gland cancer	0.000396	0.000939	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000394	0.000935	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MC3R—salivary gland cancer	0.000364	0.000864	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000358	0.000849	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—salivary gland cancer	0.000352	0.000835	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000351	0.000833	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000351	0.000832	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MARCKS—salivary gland cancer	0.000335	0.000795	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HRAS—salivary gland cancer	0.000331	0.000786	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DTX4—salivary gland cancer	0.000318	0.000755	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NUP62—salivary gland cancer	0.000314	0.000745	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PYGB—salivary gland cancer	0.000312	0.000739	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—VCAN—salivary gland cancer	0.000312	0.000739	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000311	0.000738	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCND1—salivary gland cancer	0.000311	0.000737	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PTEN—salivary gland cancer	0.0003	0.000711	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—TP53—salivary gland cancer	0.000295	0.000699	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—EP300—salivary gland cancer	0.000286	0.000678	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—HRAS—salivary gland cancer	0.00027	0.00064	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGF16—salivary gland cancer	0.000263	0.000625	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PHGDH—salivary gland cancer	0.000254	0.000603	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CREBBP—salivary gland cancer	0.00025	0.000593	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	0.000245	0.00058	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAML2—salivary gland cancer	0.000229	0.000542	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000223	0.000529	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AQP1—salivary gland cancer	0.000222	0.000527	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CREBBP—salivary gland cancer	0.000212	0.000502	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CA—salivary gland cancer	0.000212	0.000502	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TP53—salivary gland cancer	0.000205	0.000485	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HRAS—salivary gland cancer	0.000196	0.000464	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JAG1—salivary gland cancer	0.000195	0.000463	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGFR4—salivary gland cancer	0.000194	0.000461	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FBXW7—salivary gland cancer	0.000191	0.000454	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTEN—salivary gland cancer	0.000179	0.000423	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NUP62—salivary gland cancer	0.000176	0.000418	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—VCAN—salivary gland cancer	0.000175	0.000414	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—EP300—salivary gland cancer	0.00017	0.000404	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FOXO3—salivary gland cancer	0.000161	0.000383	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTEN—salivary gland cancer	0.000151	0.000358	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—EP300—salivary gland cancer	0.000144	0.000342	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAP2K2—salivary gland cancer	0.000132	0.000313	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CA—salivary gland cancer	0.000126	0.000299	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CREBBP—salivary gland cancer	0.000122	0.000289	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH1—salivary gland cancer	0.000108	0.000256	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CA—salivary gland cancer	0.000107	0.000253	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CREBBP—salivary gland cancer	9.79e-05	0.000232	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CA—salivary gland cancer	9.19e-05	0.000218	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTEN—salivary gland cancer	8.7e-05	0.000206	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CA—salivary gland cancer	8.35e-05	0.000198	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—EP300—salivary gland cancer	8.29e-05	0.000197	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HRAS—salivary gland cancer	7.73e-05	0.000183	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCND1—salivary gland cancer	7.24e-05	0.000172	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTEN—salivary gland cancer	6.99e-05	0.000166	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CREBBP—salivary gland cancer	6.83e-05	0.000162	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EP300—salivary gland cancer	6.67e-05	0.000158	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CA—salivary gland cancer	6.14e-05	0.000146	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CA—salivary gland cancer	4.93e-05	0.000117	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTEN—salivary gland cancer	4.88e-05	0.000116	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TP53—salivary gland cancer	4.77e-05	0.000113	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—EP300—salivary gland cancer	4.65e-05	0.00011	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HRAS—salivary gland cancer	4.56e-05	0.000108	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	3.44e-05	8.16e-05	CbGpPWpGaD
